Cathay Biotech Inc. (SHA:688065)

Cathay Biotech Statistics

Total Valuation

Cathay Biotech has a market cap or net worth of CNY 35.31 billion. The enterprise value is 30.20 billion.

Market Cap	35.31B
Enterprise Value	30.20B

Important Dates

The next confirmed earnings date is Friday, April 24, 2026.

Earnings Date	Apr 24, 2026
Ex-Dividend Date	Aug 1, 2025

Share Statistics

Cathay Biotech has 720.66 million shares outstanding. The number of shares has increased by 17.09% in one year.

Current Share Class	720.66M
Shares Outstanding	720.66M
Shares Change (YoY)	+17.09%
Shares Change (QoQ)	+0.56%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	14.77%
Float	263.62M

Valuation Ratios

The trailing PE ratio is 59.04 and the forward PE ratio is 42.79.

PE Ratio	59.04
Forward PE	42.79
PS Ratio	10.72
PB Ratio	1.66
P/TBV Ratio	2.09
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	53.39
EV / Sales	9.16
EV / EBITDA	31.76
EV / EBIT	47.56
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.01
Debt / EBITDA	0.29
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 3.12% and return on invested capital (ROIC) is 4.56%.

Return on Equity (ROE)	3.12%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	4.56%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	8.09%
Revenue Per Employee	1.90M
Profits Per Employee	326,064
Employee Count	1,764
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Cathay Biotech has paid 65.78 million in taxes.

Income Tax	65.78M
Effective Tax Rate	10.42%

Stock Price Statistics

The stock price has increased by +0.10% in the last 52 weeks. The beta is 0.71, so Cathay Biotech's price volatility has been lower than the market average.

Beta (5Y)	0.71
52-Week Price Change	+0.10%
50-Day Moving Average	55.12
200-Day Moving Average	50.64
Relative Strength Index (RSI)	37.08
Average Volume (20 Days)	7,297,436

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Cathay Biotech had revenue of CNY 3.30 billion and earned 565.72 million in profits. Earnings per share was 0.83.

Revenue	3.30B
Gross Profit	635.09M
Operating Income	635.09M
Pretax Income	631.50M
Net Income	565.72M
EBITDA	951.01M
EBIT	635.09M
Earnings Per Share (EPS)	0.83

Balance Sheet

The company has 9.01 billion in cash and 279.23 million in debt, with a net cash position of 8.73 billion or 12.11 per share.

Cash & Cash Equivalents	9.01B
Total Debt	279.23M
Net Cash	8.73B
Net Cash Per Share	12.11
Equity (Book Value)	21.22B
Book Value Per Share	24.98
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	315.92M
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 19.27%, with operating and profit margins of 19.27% and 17.17%.

Gross Margin	19.27%
Operating Margin	19.27%
Pretax Margin	19.16%
Profit Margin	17.17%
EBITDA Margin	28.86%
EBIT Margin	19.27%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.40, which amounts to a dividend yield of 0.82%.

Dividend Per Share	0.40
Dividend Yield	0.82%
Dividend Growth (YoY)	110.52%
Years of Dividend Growth	2
Payout Ratio	n/a
Buyback Yield	-17.09%
Shareholder Yield	-16.28%
Earnings Yield	1.60%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on July 20, 2022. It was a forward split with a ratio of 1.4.

Last Split Date	Jul 20, 2022
Split Type	Forward
Split Ratio	1.4

Scores

Altman Z-Score	n/a
Piotroski F-Score	1